市場調查報告書
商品編碼
1558342
2030 年維生素 B12 市場預測:按產品類型、形式、等級、銷售管道、應用、最終用戶和地區進行的全球分析Vitamin B12 Market Forecasts to 2030 - Global Analysis By Product Type (Cyanocobalamin, Hydroxocobalamin, Methylcobalamin and Adenosylcobalamin), Form, Grade, Sales Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球維生素 B12 市場規模為 2.113 億美元,預計到 2030 年將達到 3.506 億美元,預測期內複合年成長率為 8.8%。
維生素 B12,也稱為鈷胺素,是一種水溶性維生素,在多種身體功能中發揮重要作用。對於紅血球的形成、神經系統的維護和 DNA 合成至關重要。維生素B12在維生素中是獨一無二的,因為它含有礦物質鈷,其化合物統稱為鈷胺素,其中包括甲基鈷胺素和5-脫氧腺苷鈷胺素等活性形式,以及羥鈷胺素和氰鈷胺素等體內活性形式,也有惰性形式。因此,透過飲食和補充品攝取足夠的營養極為重要,尤其是對於高風險族群。
根據2022年3月發表在《人類營養與代謝》的論文,第二型糖尿病等慢性疾病患者維生素B12缺乏的盛行率為17.5%。
維生素 B12 缺乏症盛行率上升
隨著人們越來越認知到維生素 B12 缺乏症對健康的影響,越來越多的人正在尋求補充品來預防或控制維生素 B12 缺乏症。對於老年人、素食者和患有抑制營養吸收的胃腸道疾病的人等高風險族群尤其如此。醫療保健專業人士擴大推薦維生素 B12補充品作為標準治療通訊協定的一部分,進一步刺激了市場需求。
有限的自然資源
人們越來越依賴維生素 B12 強化食品和補充品,這是由於天然來源有限,導致市場波動,並且在可靠選擇較少的地區可能會受到限制。此外,維生素 B12補充品和強化食品製造商之間的競爭會增加行銷成本並產生價格壓力,從而阻礙市場成長,從而影響消費者信心和市場穩定。
素食者和素食者的增加
由於越來越多的素食主義者和素食者採用植物性飲食,對維生素 B12補充品的需求不斷增加。這些飲食具有很高的缺乏症風險,增加了對營養食品的需求。食品製造商正在擴大植物奶、穀物和營養酵母等強化食品的生產,以滿足該族群的營養需求,從而促進市場成長。
開發中國家認知度低
對維生素 B12 缺乏症的認知有限可能會導致病例報告不足和公共衛生工作不足,從而阻礙市場成長。因此,公司不願意投資於針對這一人群的行銷和產品開拓。此外,政府未能優先考慮微量營養素缺乏症可能會導致衛生政策不足、缺乏食品強化工作和教育宣傳活動,並進一步阻礙維生素 B12 產品的市場成長機會。
COVID-19 大流行對維生素 B12 市場產生了重大影響,隨著消費者專注於提高免疫力,導致對補充品的需求增加。健康專家和組織強調了維生素(包括 B12)在這場危機期間維持整體健康的重要性。這種意識的提高正在推動維生素 B12 產品的銷售,預計未來幾年將持續成長。
氰鈷胺部分預計將在預測期內成為最大的部分
氰鈷胺預計在預測期內成長最快,因為它被認為是維生素 B12 最穩定的形式,這有助於其在市場上的主導地位。由於其穩定性,與其他形式的維生素 B12(例如甲鈷胺和腺苷鈷胺)相比,它更容易處理並且保存期限更長。這種穩定性使得氰鈷胺的生產、儲存和運輸劣化風險較小,因其穩定的供應和可用性而成為製造商的首選。
營養食品產業預計在預測期內複合年成長率最高
由於缺乏維生素 B12補充品的需求激增,食品產業預計在預測期內將出現最高的複合年成長率。補充品傳遞技術的進步,例如舌下片劑、粉末和經皮吸收貼片,使消費者更容易將維生素 B12 融入日常生活中。
由於營養食品的使用不斷增加、以預防醫學為重點的醫療保健行業的進步以及該地區可用的產品種類繁多,北美在預測期內佔據了最大的市場佔有率。此外,神經系統和胃腸道疾病的日益普及導致該地區鈷胺素補充品的消費量增加。
亞太地區在預測期內將出現最高的複合年成長率,因為糖尿病神經病變的高患病率、人口老齡化的加劇以及保健補充品意識的提高預計將成為推動該地區成長的因素。此外,預計主要企業的存在和產能的擴大將在預計幾年內對該地區的市場成長做出重大貢獻。
According to Stratistics MRC, the Global Vitamin B12 Market is accounted for $211.3 million in 2024 and is expected to reach $350.6 million by 2030 growing at a CAGR of 8.8% during the forecast period. Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in various bodily functions. It is essential for the formation of red blood cells, maintenance of the nervous system, and DNA synthesis. Vitamin B12 is unique among vitamins because it contains the mineral cobalt, and its compounds are collectively referred to as cobalamins, which include active forms like methylcobalamin and 5-deoxyadenosylcobalamin, as well as inactive forms such as hydroxycobalamin and cyanocobalamin that convert into active forms in the body. Thus adequate intake through diet or supplementation is crucial, especially for at-risk populations.
According to the article published in Human Nutrition & Metabolism in March 2022, the prevalence of B12 deficiency in patients with chronic diseases such as type 2 diabetes was 17.5%.
Rising prevalence of vitamin B12 deficiency
As awareness of the health implications of vitamin B12 deficiency grows, more individuals are seeking supplements to prevent or address deficiencies. This is particularly true among at-risk populations, including the elderly, vegetarians, and those with gastrointestinal disorders that impair nutrient absorption. Healthcare professionals are increasingly recommending vitamin B12 supplements as part of standard treatment protocols, further boosting market demand
Limited natural sources
The growing dependency on fortified foods and supplements for vitamin B12 is due to limited natural sources, leading to market fluctuations and potential limitations in regions with less trusted options. Additionally, competition among manufacturers of vitamin B12 supplements and fortified foods creates increased marketing costs and pricing pressures, potentially affecting consumer trust and market stability hampering the market growth.
Increase in vegan and vegetarian populations
The demand for vitamin B12 supplements is increasing due to the increasing number of vegans and vegetarians adopting plant-based diets. These diets are at a higher risk of deficiency, leading to a need for dietary supplements. Food manufacturers are expanding fortified food products, such as plant-based milks, cereals, and nutritional yeast, to meet the nutritional needs of these populations, contributing to market growth.
Limited awareness in developing countries
Limited awareness about vitamin B12 deficiency can lead to underreporting of cases, causing insufficient public health initiatives and hindering market growth. This can result in companies hesitant to invest in marketing or product development for these populations. Additionally, inadequate health policies can result from governments not prioritizing micronutrient deficiencies, leading to a lack of food fortification initiatives and educational campaigns, further stunting market growth opportunities for vitamin B12 products.
The COVID-19 pandemic has significantly impacted the vitamin B12 market, leading to increased demand for supplements as consumers focus on boosting their immunity. Health experts and organizations have emphasized the importance of vitamins, including B12, in maintaining overall health during the crisis. This heightened awareness has driven sales of vitamin B12 products, with expectations for continued growth in the coming years.
The cyanocobalamin segment is expected to be the largest during the forecast period
The cyanocobalamin is expected to be the largest during the forecast period because cyanocobalamin is recognized as the most stable form of vitamin B12, which contributes to its dominant position in the market. Its stability allows for easier handling and longer shelf life compared to other forms of vitamin B12, such as methylcobalamin or adenosylcobalamin. This stability makes cyanocobalamin a preferred choice for manufacturers, as it can be produced, stored, and transported with less risk of degradation, thus ensuring consistent supply and availability
The dietary supplements segment is expected to have the highest CAGR during the forecast period
The dietary supplements segment is expected to have the highest CAGR during the forecast period owing to surge in demand for Vitamin B12 supplements due to their higher risk of deficiency. Technological advancements in supplement delivery, such as sublingual tablets, powders, and transdermal patches, have made it easier for consumers to incorporate Vitamin B12 into their daily routines.
North America is projected to hold the largest market share during the forecast period attributed to an increase in the use of dietary supplements, the advanced healthcare sector focusing on preventative care, and the availability of a wide range of products in the region. In addition, the growing prevalence of neural conditions and gastrointestinal issues is leading to an increased consumption of cobalamin supplements in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period owing to the high prevalence of diabetic neuropathy, growth in the geriatric population, and rising awareness regarding health supplements are the factors anticipated to drive the region's growth. Moreover, the presence of key players and their growing production capacities are poised to significantly contribute to the region's market growth over projected years.
Key players in the market
Some of the key players in Vitamin B12 market include BASF SE , Adisseo, BTSA Biotechnologias Aplicadas S.L., Chem Kart India Pvt Ltd, DSM, Farbest Brands, Lonza Group, Merck KGaA, NOW Foods, NutraGenesis LLC, Nutrilo GmbH, Pfizer Inc, Pharmavit GmbH, Rabar Pty Ltd, Rousselot, Spectrum Chemical Manufacturing Corp., SternVitamin GmbH & Co. K.G., Thermo Fisher Scientifica and Zhejiang Shengda Bio-Pharm Co., Ltd.
In July 2024, BASF has recently launched Haptex(R) 4.0, a next-generation polyurethane solution designed to revolutionize the production of sustainable synthetic leather. This innovative material is notable for being 100% recyclable, addressing long-standing challenges in the recycling of synthetic leather
In July 2024, Thermo Fisher Scientific has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishers, Ind., that helps assess risk of early acute rejection in kidney transplant recipients, providing data that may inform a more personalized approach to post-transplant immunosuppression management.
In June 2024, BASF and 'Pragati' extended full transparency & traceability to bio-based footwear solutions with SuCCESS code. It establishes a global standard for certifying castor oil and its derivatives, such as bio-based polyurethane, used in footwear manufacturing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.